Avalo Therapeutics Inc (AVTX) Insider Trading

Total insider buys:
  • $1,964,351.39
Total insider sells:
  • $1,675,144.18
Most recent insider trade:
  • Nov. 12, 2024
Most active insider trader:
  • Caissa Capital Management Ltd.
Trader NameDateTitleAmountPriceTypeTotal Value
Nov. 12, 2024Director500$12.50Buy$6,250.00
June 26, 2023Major Shareholder2,746,138$0.61Sell$1,675,144.18
June 20, 2023Major Shareholder2,000$4.14Buy$8,280.00
June 16, 2023Major Shareholder3,000$3.90Buy$11,700.00
June 14, 2023Major Shareholder6,000$3.48Buy$20,880.00
June 12, 2023Major Shareholder2,149$4.34Buy$9,326.66
June 9, 2023CFO511$3.42Buy$1,747.62
June 9, 2023CEO4,000$3.42Buy$13,680.00
May 30, 2023Major Shareholder671$2.87Buy$1,925.77
May 25, 2023Major Shareholder2,000$2.77Buy$5,540.00
May 22, 2023Major Shareholder7,000$3.34Buy$23,380.00
May 18, 2023Major Shareholder13,121$3.29Buy$43,168.09
May 15, 2023Major Shareholder1,715$2.55Buy$4,373.25
May 12, 2023Major Shareholder2,285$2.45Buy$5,598.25
May 8, 2023Major Shareholder5,000$2.62Buy$13,100.00
May 4, 2023Major Shareholder15,000$2.79Buy$41,850.00
April 26, 2023Major Shareholder425$2.97Buy$1,262.25
April 24, 2023Major Shareholder12,500$3.06Buy$38,250.00
April 20, 2023Major Shareholder5,000$3.08Buy$15,400.00
April 17, 2023Major Shareholder15,000$2.96Buy$44,400.00
April 10, 2023Major Shareholder31,329$2.28Buy$71,430.12
Dec. 9, 2022CEO2,083$4.42Buy$9,206.86
March 14, 2022Director100,000$0.65Buy$65,000.00
March 10, 2022Director26,000$0.70Buy$18,200.00
March 7, 2022Director325,000$0.66Buy$214,500.00
March 3, 2022Director50,000$0.71Buy$35,500.00
Feb. 24, 2022Director100,000$0.80Buy$80,000.00
Feb. 22, 2022Director83,000$0.77Buy$63,910.00
Feb. 17, 2022Director150,000$0.81Buy$121,500.00
Jan. 20, 2022Director12,000$0.85Buy$10,200.00
Jan. 18, 2022Director206,300$0.88Buy$181,544.00
Jan. 14, 2022Director85,000$0.93Buy$79,050.00
Jan. 12, 2022Director57,300$1.04Buy$59,592.00
Jan. 10, 2022Director491,097$0.99Buy$486,186.03
Jan. 7, 2022Director137,900$1.04Buy$143,416.00
Dec. 10, 2021CAO955$1.57Buy$1,499.35
Dec. 10, 2021Insider6,371$1.57Buy$10,002.47
Dec. 10, 2021CFO2,231$1.57Buy$3,502.67
First«1 of 1»Last
  • Insiders are both buying and selling Avalo Therapeutics Inc stock.

  • The insider traders at Avalo Therapeutics Inc are: Caissa Capital Management Ltd., Armistice Capital, Llc, Garry Arthur Neil, Christopher Ryan Sullivan, H Jeffrey Wilkins, June Sherie Almenoff, and Schond L Greenway

  • The most active insider trader at Avalo Therapeutics Inc is Caissa Capital Management Ltd. with 17 trades.

  • Armistice Capital, Llc has sold the most Avalo Therapeutics Inc stock with a total value of $3,350,288.36.

  • Armistice Capital, Llc has bought the most Avalo Therapeutics Inc stock with a total value of $1,623,598.03.

  • The most recent insider trade for Avalo Therapeutics Inc was on Nov. 12, 2024.

  • The single biggest insider buy for Avalo Therapeutics Inc was from Armistice Capital, Llc with a total value of $486,186.03 on Jan. 10, 2022.

  • The single biggest insider sell for Avalo Therapeutics Inc was from Armistice Capital, Llc with a total value of $1,675,144.18 on June 26, 2023.